CDAK Annual CAPEX
$3.25 M
-$17.81 M-84.59%
31 December 2021
Summary:
As of February 5, 2025, CDAK annual capital expenditures is $3.25 million, with the most recent change of -$17.81 million (-84.59%) on December 31, 2021.CDAK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDAK Quarterly CAPEX
$9000.00
-$162.00 K-94.74%
30 September 2022
Summary:
As of February 5, 2025, CDAK quarterly capital expenditures is $9000.00, with the most recent change of -$162.00 thousand (-94.74%) on September 30, 2022. Over the past year, it has dropped by -$539.00 thousand (-98.36%).CDAK Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDAK TTM CAPEX
$694.00 K
-$539.00 K-43.71%
30 September 2022
Summary:
As of February 5, 2025, CDAK TTM capital expenditures is $694.00 thousand, with the most recent change of -$539.00 thousand (-43.71%) on September 30, 2022. Over the past year, it has dropped by -$3.38 million (-82.97%).CDAK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDAK CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -84.6% | -98.4% | -83.0% |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
CDAK CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -84.6% | -99.9% | -96.7% |
Codiak BioSciences CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2022 | - | $9000.00(-94.7%) | $694.00 K(-43.7%) |
June 2022 | - | $171.00 K(-6.0%) | $1.23 M(-35.1%) |
Mar 2022 | - | $182.00 K(-45.2%) | $1.90 M(-41.4%) |
Dec 2021 | $3.25 M | $332.00 K(-39.4%) | $3.25 M(-20.3%) |
Sept 2021 | - | $548.00 K(-34.7%) | $4.07 M(-23.6%) |
June 2021 | - | $839.00 K(-45.0%) | $5.33 M(-37.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | $1.53 M(+31.4%) | $8.51 M(-59.6%) |
Dec 2020 | $21.05 M(+101.0%) | $1.16 M(-35.7%) | $21.05 M(+5.8%) |
Sept 2020 | - | $1.81 M(-55.1%) | $19.89 M(+10.0%) |
June 2020 | - | $4.02 M(-71.4%) | $18.09 M(+28.6%) |
Mar 2020 | - | $14.06 M | $14.06 M |
Dec 2019 | $10.48 M | - | - |
FAQ
- What is Codiak BioSciences annual capital expenditures?
- What is the all time high annual CAPEX for Codiak BioSciences?
- What is Codiak BioSciences annual CAPEX year-on-year change?
- What is Codiak BioSciences quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Codiak BioSciences?
- What is Codiak BioSciences quarterly CAPEX year-on-year change?
- What is Codiak BioSciences TTM capital expenditures?
- What is the all time high TTM CAPEX for Codiak BioSciences?
- What is Codiak BioSciences TTM CAPEX year-on-year change?
What is Codiak BioSciences annual capital expenditures?
The current annual CAPEX of CDAK is $3.25 M
What is the all time high annual CAPEX for Codiak BioSciences?
Codiak BioSciences all-time high annual capital expenditures is $21.05 M
What is Codiak BioSciences annual CAPEX year-on-year change?
Over the past year, CDAK annual capital expenditures has changed by -$17.81 M (-84.59%)
What is Codiak BioSciences quarterly capital expenditures?
The current quarterly CAPEX of CDAK is $9000.00
What is the all time high quarterly CAPEX for Codiak BioSciences?
Codiak BioSciences all-time high quarterly capital expenditures is $14.06 M
What is Codiak BioSciences quarterly CAPEX year-on-year change?
Over the past year, CDAK quarterly capital expenditures has changed by -$539.00 K (-98.36%)
What is Codiak BioSciences TTM capital expenditures?
The current TTM CAPEX of CDAK is $694.00 K
What is the all time high TTM CAPEX for Codiak BioSciences?
Codiak BioSciences all-time high TTM capital expenditures is $21.05 M
What is Codiak BioSciences TTM CAPEX year-on-year change?
Over the past year, CDAK TTM capital expenditures has changed by -$3.38 M (-82.97%)